Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methocarbamol vs Oxybutynin for Pain Management Post-Ureteroscopy
NCT05100017Active, not recruiting
- Sponsor
- Northwestern University
- Start
- Sep 2021
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of methocarbamol in Ureteral spasm and pain (2 arms), sponsored by Northwestern University. Primary endpoints: Patient discomfort/pain after ureteroscopy and ureteral stent placement at 1 week and Patient ureteral stent symptoms after ureteroscopy and ureteral stent placement at 1 week. Started Sep 2021; status: active, not recruiting.
02
Drugs
methocarbamol
03
Conditions
Ureteral spasmpain
Beyond the preview
Go deeper on NCT05100017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05100017.